Italian guidelines for the management and treatment of neonatal cholestasis

Area of Science:

• Neonatology
• Pediatric Gastroenterology
• Clinical Pediatrics

Background:

• Hyperbilirubinemia is common in newborns, with prolonged jaundice (over 14 days) necessitating further investigation.
• Differentiating between benign unconjugated hyperbilirubinemia and pathological conjugated hyperbilirubinemia, often indicative of neonatal cholestasis, is critical.
• Delayed diagnosis of neonatal cholestasis can lead to adverse outcomes and unnecessary medical interventions.

Purpose of the Study:

• To present shared Italian guidelines for the management and treatment of neonatal cholestasis.
• To provide a practical tool for neonatologists and pediatricians in assessing and managing prolonged jaundice.
• To emphasize the importance of timely diagnosis for optimizing patient outcomes and reducing healthcare costs.

Main Methods:

• Development of consensus-based guidelines by the Task Force on Hyperbilirubinemia of the Italian Society of Neonatology.
• Review of current literature and clinical best practices for neonatal cholestasis.
• Structured framework for differential diagnosis and management strategies.

Main Results:

• Established clear diagnostic criteria for prolonged jaundice and neonatal cholestasis.
• Outlined a stepwise approach to the assessment and management of neonatal cholestasis.
• Provided recommendations for appropriate investigations and treatment interventions.

Conclusions:

• The guidelines offer a standardized approach to neonatal cholestasis, improving diagnostic accuracy and timeliness.
• Effective management of neonatal cholestasis relies on prompt identification and appropriate intervention.
• These guidelines aim to enhance the care of newborns with prolonged jaundice, ensuring optimal health outcomes.